Female risk factors for subarachnoid hemorrhage: A systematic review

Neurology

Volumn 79, Issue 12, 2012, Pages 1230-1236

  Algra, Annemijn M ^a,b   Klijn, Catharina J M ^a   Helmerhorst, Frans M ^b   Algra, Ale ^a,b,c   Rinkel, Gabriël J E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

BREAST FEEDING; CARDIOVASCULAR RISK; CONTRACEPTION; EMBASE; FEMALE; HORMONE SUBSTITUTION; HUMAN; LABOR; MEDLINE; MENARCHE; MENSTRUAL CYCLE; PARITY; POSTMENOPAUSE; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; REVIEW; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW;

EID: 84867561517     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31826aace6     Document Type: Article

References (29)

1. de Rooij NK, Linn FH, van der Plas JA, Algra A, Rinkel GJ. Incidence of subarachnoid haemorrhage: A systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry 2007;78:1365-1372.
2. Vlak MH, Algra A, Brandenburg R, Rinkel GJ. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: A systematic review and meta-analysis. Lancet Neurol 2011;10: 626-636.
3. Feigin VL, Rinkel GJ, Lawes CM, et al. Risk factors for subarachnoid hemorrhage: An updated systematic review of epidemiological studies. Stroke 2005;36:2773-2780.
4. Ruigrok YM, Buskens E, Rinkel GJ. Attributable risk of common and rare determinants of subarachnoid hemorrhage. Stroke 2001;32:1173-1175.
5. Wolf PA, D'Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke: The Framingham Study. JAMA 1988;259:1025-1029.
6. Gill JS, Zezulka AV, Shipley MJ, Gill SK, Beevers DG. Stroke and alcohol consumption. N Engl J Med 1986;315: 1041-1046.
7. Five-year findings of the Hypertension Detection and Follow-up Program: III: Reduction in stroke incidence among persons with high blood pressure: Hypertension Detection and Follow-up Program Cooperative Group. JAMA 1982;247:633-638.
8. Bonita R. Cigarette smoking, hypertension and the risk of subarachnoid hemorrhage: A population-based casecontrol study. Stroke 1986;17:831-835.
9. Thorogood M, Mann J, Murphy M, Vessey M. Fatal stroke and use of oral contraceptives: Findings from a casecontrol study. Am J Epidemiol 1992;136:35-45.
10. Longstreth WT, Nelson LM, Koepsell TD, Van Belle G. Subarachnoid hemorrhage and hormonal factors in women: A population-based case-control study. Ann Intern Med 1994;121:168-173.
11. Hannaford PC, Croft PR, Kay CR. Oral contraception and stroke: Evidence from the Royal College of General Practitioners' Oral Contraception Study. Stroke 1994;25:935-942.
12. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: Results of an international, multicentre, case-control study: WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet 1996;348:505-510.
13. Schwartz SM, Siscovick DS, Longstreth WT Jr, et al. Use of low-dose oral contraceptives and stroke in young women. Ann Intern Med 1997;127:596-603.
14. Pedersen AT, Lidegaard O, Kreiner S, Ottesen B. Hormone replacement therapy and risk of non-fatal stroke. Lancet 1997;350:1277-1283.
15. Mhurchu CN, Anderson C, Jamrozik K, Hankey G, Dunbabin D. Hormonal factors and risk of aneurysmal subarachnoid hemorrhage: An international population-based, case-control study. Stroke 2001;32:606-612.
16. Wassertheil-Smoller S, Hendrix SL, Limacher M, et al. Effect of estrogen plus progestin on stroke in postmenopausal women: The Women's Health Initiative: A randomized trial. JAMA 2003;289:2673-2684.
17. Grodstein F, Stampfer MJ, Manson JE, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453-461.
18. Lindekleiv H, Sandvei MS, Njolstad I, et al. Sex differences in risk factors for aneurysmal subarachnoid hemorrhage: A cohort study. Neurology 2011;76:637-643.
19. Park JK, Kim HJ, Chang SJ, Koh SB, Koh SY. Risk factors for hemorrhagic stroke in Wonju, Korea. Yonsei Med J 1998;39:229-235.
20. Gaist D, Pedersen L, Cnattingius S, Sorensen HT. Parity and risk of subarachnoid hemorrhage in women: A nested case-control study based on national Swedish registries. Stroke 2004;35:28-32.
21. Tiel Groenestege AT, Rinkel GJ, van der Bom JG, Algra A, Klijn CJ. The risk of aneurysmal subarachnoid hemorrhage during pregnancy, delivery, and the puerperium in the Utrecht population: Case-crossover study and standardized incidence ratio estimation. Stroke 2009; 40:1148-1151.
22. Okamoto K, Horisawa R, Kawamura T, et al. Menstrual and reproductive factors for subarachnoid hemorrhage risk in women: A case-control study in Nagoya, Japan. Stroke 2001;32:2841-2844.
23. Jung SY, Bae HJ, Park BJ, Yoon BW. Parity and risk of hemorrhagic strokes. Neurology 2010;74:1424-1429.
24. Wells G, Shea B, O'Connell D, et al. The Newcastle- Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available at: Http://www.ohri.ca/programs/clinical-epidemiology/oxford. htm. Accessed December 15, 2011.
25. Johnston SC, Colford JM Jr, Gress DR. Oral contraceptives and the risk of subarachnoid hemorrhage: A metaanalysis. Neurology 1998;51:411-418.
26. Greiser CM, Greiser EM, Doren M. Menopausal hormone therapy and risk of ovarian cancer: Systematic review and meta-analysis. Hum Reprod Update 2007;13:453-463.
27. Lee SA, Ross RK, Pike MC. An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk. Br J Cancer 2005;92:2049-2058.
28. Mosher WD, Jones J. Use of contraception in the United States: 1982-2008. Vital Health Stat 23 2010;1-44. Available at: Http://www.cdc.gov/nchs/data/ series/sr-23/sr23-029.pdf. Accessed March 25, 2012.
29. Oral contraceptives, combined. IARC Monographs 1999;72. Available at: Http://monographs.iarc.fr/ENG/Monographs/vol72/mono72-6A.pdf. Accessed March 25, 2012.